Cresco Labs Statistics

Total Valuation

Cresco Labs has a market cap or net worth of CAD 581.17 million. The enterprise value is 1.18 billion.

Market Cap	581.17M
Enterprise Value	1.18B

Important Dates

The last earnings date was Monday, November 11, 2024.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

Cresco Labs has 348.00 million shares outstanding. The number of shares has increased by 9.10% in one year.

Current Share Class	n/a
Shares Outstanding	348.00M
Shares Change (YoY)	+9.10%
Shares Change (QoQ)	+0.70%
Owned by Insiders (%)	1.19%
Owned by Institutions (%)	5.55%
Float	327.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.58
PB Ratio	0.94
P/TBV Ratio	n/a
P/FCF Ratio	5.47
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.13, with an EV/FCF ratio of 11.14.

EV / Earnings	-12.99
EV / Sales	1.21
EV / EBITDA	4.13
EV / EBIT	7.46
EV / FCF	11.14

Financial Position

The company has a current ratio of 1.97, with a Debt / Equity ratio of 1.89.

Current Ratio	1.97
Quick Ratio	1.31
Debt / Equity	1.89
Debt / EBITDA	3.25
Debt / FCF	8.79
Interest Coverage	1.95

Financial Efficiency

Return on equity (ROE) is -14.17% and return on invested capital (ROIC) is 6.75%.

Return on Equity (ROE)	-14.17%
Return on Assets (ROA)	5.27%
Return on Capital (ROIC)	6.75%
Revenue Per Employee	327,088
Profits Per Employee	-30,365
Employee Count	2,760
Asset Turnover	0.52
Inventory Turnover	3.48

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.39% in the last 52 weeks. The beta is 1.97, so Cresco Labs's price volatility has been higher than the market average.

Beta (5Y)	1.97
52-Week Price Change	-27.39%
50-Day Moving Average	2.11
200-Day Moving Average	2.41
Relative Strength Index (RSI)	36.57
Average Volume (20 Days)	295,278

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cresco Labs had revenue of CAD 981.27 million and -91.10 million in losses. Loss per share was -0.27.

Revenue	981.27M
Gross Profit	494.79M
Operating Income	158.51M
Pretax Income	-1.15M
Net Income	-91.10M
EBITDA	246.92M
EBIT	158.51M
Loss Per Share	-0.27

Full Income Statement

Balance Sheet

The company has 207.09 million in cash and 932.76 million in debt, giving a net cash position of -725.67 million or -2.09 per share.

Cash & Cash Equivalents	207.09M
Total Debt	932.76M
Net Cash	-725.67M
Net Cash Per Share	-2.09
Equity (Book Value)	493.59M
Book Value Per Share	1.77
Working Capital	207.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 134.68 million and capital expenditures -28.51 million, giving a free cash flow of 106.17 million.

Operating Cash Flow	134.68M
Capital Expenditures	-28.51M
Free Cash Flow	106.17M
FCF Per Share	0.31

Full Cash Flow Statement

Margins

Gross margin is 50.42%, with operating and profit margins of 16.15% and -9.28%.

Gross Margin	50.42%
Operating Margin	16.15%
Pretax Margin	-0.12%
Profit Margin	-9.28%
EBITDA Margin	25.16%
EBIT Margin	16.15%
FCF Margin	10.82%

Dividends & Yields

Cresco Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.10%
Shareholder Yield	-9.10%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cresco Labs has an Altman Z-Score of -0.06. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.06
Piotroski F-Score	n/a